VitaNova Life Sciences Corporation (VNOV)

Market Cap	25.01M -37.9%
Revenue (ttm)	3.24M +22.0%
Net Income	-114.10K
EPS	-0.01
Shares Out	8.34M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	3.000
Previous Close	4.476
Day's Range	3.000 - 3.000
52-Week Range	1.348 - 4.700
Beta	-0.48
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 16, 2026

About VitaNova Life Sciences

VitaNova Life Sciences a consumer health, beauty and lifestyle company, develops, acquires, markets, and sells branded nutritional supplements, functional beverages, and complementary lifestyle products in the United States, Hong Kong, China, and internationally. It operates through two segments, Dietary Supplement and Food Products segment. The company develops and sells nutritional supplements under the GeneCode and AMZ brand names. It is also involved in the sale of healthy food products, including olive juice, white sesame oil, aloe vera dr...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2017
• Employees: 7
• Stock Exchange: OTCMKTS
• Ticker Symbol: VNOV

Financial Performance

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 30, 2026

Data Sources Report a data error